Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 18 January

Grady Wulff
January 18, 2024

Morning Bell 17 January

Grady Wulff
January 17, 2024

Morning Bell 16 January

Grady Wulff
January 16, 2024

Morning Bell 15 January

Sophia Mavridis
January 15, 2024

Weekly Wrap 15 December

Grady Wulff
December 15, 2023

Morning Bell 14 December

Grady Wulff
December 14, 2023

Morning Bell 13 December

Grady Wulff
December 13, 2023

Morning Bell 12 December

Grady Wulff
December 12, 2023

Morning Bell 11 December

Grady Wulff
December 11, 2023

Weekly Wrap 8 December

Sophia Mavridis
December 8, 2023